z-logo
Premium
Comparison of skin cancers in liver and renal transplant recipients: Results of a prospective study in an Australian tertiary referral centre
Author(s) -
Ge Ludi,
Chee ShienNing,
Robledo Kristy P,
Lowe Patricia
Publication year - 2018
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.12759
Subject(s) - medicine , basal cell carcinoma , skin cancer , odds ratio , univariate analysis , tertiary referral centre , transplantation , population , prospective cohort study , multivariate analysis , basal cell , surgery , cancer , environmental health
Abstract Background/Objectives Organ transplant recipients ( OTR ) have an increased risk of skin cancers compared with the general population. Methods A prospective study of renal ( RTR ) and liver transplant recipients ( LTR ) was conducted in a single New South Wales tertiary referral centre over 60 months. Initial and subsequent visit data were recorded in our transplant database. Only patients with a minimum of 11 months follow up were included. Results Altogether 142 RTR and 88 LTR were included in the analysis. Compared with RTR , the median age of liver transplant recipients was higher (64 vs 57 years), more men were patients (73 vs 60%) and there were higher rates of high‐risk skin types (54 vs 33%) and heavy sun exposure (43 vs 30%). RTR developed 304 non‐melanoma skin cancers ( NMSC ) with a squamous cell carcinoma:basal cell carcinoma ratio of 1.7:1. LTR developed 205 NMSC with a squamous cell carcinoma:basal cell carcinoma ratio of 1.6:1. The odds ratio of developing NMSC in LTR : RTR was 1.8:1 (95% CI : 1.02–3.11, P = 0.044) on univariate analysis but there was no difference on multivariate analysis. A previous history of NMSC , age, time from transplant from first visit, skin phenotype and previous sun exposure were significant risk factors for developing NMSC . Conclusions Liver transplant recipients are not at a lower risk of NMSC than RTR . Our study supports routine and regular post‐transplant skin surveillance of all LTR , like other OTR .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom